You have 9 free searches left this month | to do more

mbg453

Mbg453 is a drug used to treat Myelodysplastic Syndromes, Acute Myeloid Leukemia, Advanced Malignancies, and other conditions. Mbg453 is being actively studied in 10 studies; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
Novartis PharmaceuticalsNovartis Investigative SiteAndrew Mark Brunner, MD
Massachusetts General HospitalMD Anderson Cancer Center/University of Texas MD Anderson
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsMassachusetts General Hospital
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Not yet recruiting
  • Myelodysplastic Syndromes
  • MBG453
  • Boston, Massachusetts
  • +2 more
2021-03-28
Mar 28, 2021
N
Not yet recruiting
  • Myelodysplastic Syndrome (MDS)
  • MBG453
  • +3 more
  • (no location specified)
2021-12-09
Dec 9, 2021
N
Recruiting
  • Acute Myeloid Leukemia (AML)
  • High-risk Myelodysplastic Syndrome (MDS)
  • Durham, North Carolina
  • +8 more
2021-12-03
Dec 3, 2021
N
Active, not recruiting
  • Leukemia
  • +7 more
  • Boston, Massachusetts
  • +10 more
2021-10-14
Oct 14, 2021
N
Active, not recruiting
  • Advanced Malignancies
  • MBG453
  • +2 more
  • Baltimore, Maryland
  • +13 more
2021-12-09
Dec 9, 2021
N
Recruiting
  • Acute Myeloid Leukemia
  • MBG453
  • +2 more
  • San Francisco, California
  • +20 more
2021-12-13
Dec 13, 2021
N
Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • MBG453
  • +3 more
  • (no location specified)
2021-03-02
Mar 2, 2021
S
Recruiting
  • Glioblastoma Multiforme
  • MBG453
  • Stanford, California
  • +1 more
2021-11-01
Nov 1, 2021
N
Active, not recruiting
  • Myelodysplastic Syndromes
  • MBG453
  • +2 more
  • Duarte, California
  • +46 more
2021-12-15
Dec 15, 2021
N
Recruiting
  • Myelodysplastic Syndromes
  • MBG453
  • +2 more
  • Houston, Texas
  • +7 more
2021-12-03
Dec 3, 2021